Effect of labrasol on self-nanoemulsification efficiency of ramipril nanoemulsion

Pharmazie

Volumn 64, Issue 12, 2009, Pages 812-817

  Shafiq, Sheikh ^a   Shakeel, F ^b  

^a ZYDUS RESEARCH CENTRE   (India)

^b AL ARAB MEDICAL UNIVERSITY   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

COSURFACTANT; DIETHYLENE GLYCOL MONOETHYL ETHER; LABRASOL; PROPANEDIOL DERIVATIVE; RAMIPRIL; SURFACTANT;

ARTICLE; CENTRIFUGATION; COOLING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; FREEZE THAWING; HEATING; NANOEMULSION; THERMODYNAMICS;

ANTIHYPERTENSIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG STABILITY; EMULSIONS; EXCIPIENTS; NANOPARTICLES; ORGANIC CHEMICALS; RAMIPRIL; SOLUBILITY; THERMODYNAMICS;

EID: 75749154095     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.9186     Document Type: Article

References (25)

1. Charman SA, Charman WN, Rogge MC,Wilson TD, Dutko FJ, PoutonCW (1992) Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 9: 87-93.
2. Constantinides PP (1995) Lipid microemulsions for improving drug dissolution and oral absorption and biopharmaceutical aspects. Pharm Res 12: 1561-1572.
3. Craig DQM, Barker SA, Banning D, BoothSW(1995) An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 114: 103-410.
4. Date AA, Nagarsenker MS (2007) Design and evaluation of selfnanoemulsified drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 329: 166-172.
5. Griensven JMV, Schoemaker RC, Cohen AF, Luus HG, Grafe MS, Rothig HJ (1995) Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril. Eur J Clin Pharmacol 47: 513-518.
6. Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ (1998) Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorlywater-soluble LTB4 inhibitor. J Pharm Sci 87: 164-169.
7. Hogan BL, Williams M, Idiculla A, Veysoglu T, Parente E (2000) Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules. J Pharm Biomed Anal 23: 637-651.
8. Karim A, Gokhale R, Cole M, Sherman J, Yeramian P, Bryant M, Franke H (1994) HIV protease inhibitor SC-52151: a novel method of optimizing bioavailability profile via a microemulsion drug delivery system. Pharm Res 11: S368.
9. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Masuda K (2002a) Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J Control Release 81: 65-74.
10. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, NishiharaY, MasudaK(2002b) Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study. J Control Release 81: 75-82.
11. Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN (1998) Formulation design and bioavailability assessment of lipidic selfemulsifying formulations of halofantrine. Int J Pharm 167: 155-164.
12. Kimura M, Shizuki M, Miyoshi K, Sakai T, Hidaka H, Takamura H, Matoba T (1994) Relationship between the molecular structures and emulsification properties of edible oils. Biosci Biotech Biochem 58: 1258-61.
13. 10: formulation development and bioavailability assessment. Int J Pharm 212: 233-246.
14. Lawrence MJ, Rees GD (2000) Microemulsion-based media as novel drug delivery systems. Adv Drug Del Rev 45: 89-121.
15. Palin KJ, Phillips AJ, Ning A (1986) The oral absorption of cefoxitin from oil and emulsion vehicles in rats. Int J Pharm 33: 99-104.
16. Ping L, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin ATM (2005) Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm 288: 27-34.
17. Serajuddin ATM, Shee PC, Mufson D, Bernstein DF, AugustineMA(1988) Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water soluble drug from solid dispersion. J Pharm Sci 77: 414-417.
18. Shafiq S, Shakeel F (2008) Enhanced stability of ramipril in nanoemulsion containing Cremophor-EL: a technical note. AAPS Pharm Sci Tech 9: 1097-1101.
19. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M (2007a) Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66: 227-242.
20. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M (2007b) Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment. J Biomed Nanotechnol 3: 28-44.
21. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2008a) Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol 6: E8.
22. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2008b) Celecoxib nanoemulsion: Skin permeation mechanism and bioavailability assessment. J Drug Target 16: 733-740.
23. Stella VJ, Haslam J, Yata N, Okada H, Lindenbaum S, Higuchi T (1978) Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. J Pharm Sci 67: 1375-1377.
24. Toguchi H, OgawaY, Iga K,Yashiki T, Shimamoto T (1990) Gastrointestinal absorption of ethyl 2-chloro-3-(4-(2-methyl-2-phenylpropyloxy) phenyl) propionate from different dosage forms in rats and dogs. Chem Pharm Bull 38: 2792-2796.
25. J, Chang Q, Chan CK,MengZY,Wang GN, Sun JB,WangYT,TongHHY, Zheng Y (2009) Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS Pharm Sci Tech 10: 172-182.